Literature DB >> 7695046

Spontaneous and ethanol-stimulated in vitro release of beta-endorphin by the hypothalamus of AA and ANA rats.

J P de Waele1, K Kiianmaa, C Gianoulakis.   

Abstract

Previous studies demonstrated that both the spontaneous and ethanol-stimulated release of beta-endorphin (beta-EP) like-peptides (beta-EPLPs) by the hypothalami of the ethanol-preferring C57BL/6 mice is more pronounced than by the hypothalami of the ethanol-avoiding DBA/2 mice. The objective of the present studies was to investigate the effects of various concentrations of ethanol on the in vitro release of beta-EP peptides by the hypothalami of the ethanol-preferring Alko-Alcohol (AA) and ethanol-avoiding Alko Non-Alcohol (ANA) lines of rats. Results indicated that although the spontaneous release of hypothalamic beta-EPLPs was higher by the ANA than by the AA rats, the percentage increase following exposure to various concentrations of ethanol was similar in both lines of rats. Furthermore, the release of hypothalamic beta-EPLPs following exposure to 30 mM ethanol was significantly higher than the release following exposure to 10 mM ethanol in the AA, but not the ANA, rats. Analysis of the released beta-EPLPs with Sephadex G-75 and reversed phase HPLC indicated that the nonacetylated beta-EP 1-31 was the major component in the hypothalamic perifusates of the AA rats, whereas the shorter and acetylated forms of beta-EP were the predominant components in the hypothalamic perifusates of the ANA rats. Because the shorter and acetylated forms of beta-EP are devoid of opioid activity, their pronounced release by the hypothalami of the ANA rats may be important in maintaining their low ethanol consumption, even after long-term access to ethanol solutions.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7695046     DOI: 10.1111/j.1530-0277.1994.tb01452.x

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  12 in total

1.  Intravenous heroin and ethanol self-administration by alcohol-preferring AA and alcohol-avoiding ANA rats.

Authors:  P Hyytiä; G Schulteis; G F Koob
Journal:  Psychopharmacology (Berl)       Date:  1996-06       Impact factor: 4.530

Review 2.  Human and laboratory rodent low response to alcohol: is better consilience possible?

Authors:  John C Crabbe; Richard L Bell; Cindy L Ehlers
Journal:  Addict Biol       Date:  2010-04       Impact factor: 4.280

Review 3.  The opioidergic-alcohol link : implications for treatment.

Authors:  Vania Modesto-Lowe; Eleanor M Fritz
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 4.  Influence of the endogenous opioid system on high alcohol consumption and genetic predisposition to alcoholism.

Authors:  C Gianoulakis
Journal:  J Psychiatry Neurosci       Date:  2001-09       Impact factor: 6.186

Review 5.  Animal models for medications development targeting alcohol abuse using selectively bred rat lines: neurobiological and pharmacological validity.

Authors:  Richard L Bell; Helen J K Sable; Giancarlo Colombo; Petri Hyytia; Zachary A Rodd; Lawrence Lumeng
Journal:  Pharmacol Biochem Behav       Date:  2012-07-25       Impact factor: 3.533

6.  Glycyl-glutamine reduces ethanol intake at three reward sites in P rats.

Authors:  Garth E Resch; C Wayne Simpson
Journal:  Alcohol       Date:  2008-03       Impact factor: 2.405

7.  Cyclo-glycyl-glutamine inhibits ethanol intake in P and Sprague-Dawley rats.

Authors:  Garth E Resch; C Wayne Simpson
Journal:  Peptides       Date:  2007-11-22       Impact factor: 3.750

8.  Suppression of ethanol-reinforced behavior by naltrexone is associated with attenuation of the ethanol-induced increase in dialysate dopamine levels in the nucleus accumbens.

Authors:  R A Gonzales; F Weiss
Journal:  J Neurosci       Date:  1998-12-15       Impact factor: 6.167

9.  A microdialysis profile of beta-endorphin and catecholamines in the rat nucleus accumbens following alcohol administration.

Authors:  Peter W Marinelli; Rémi Quirion; Christina Gianoulakis
Journal:  Psychopharmacology (Berl)       Date:  2003-05-21       Impact factor: 4.530

Review 10.  Targeting endogenous mu- and delta-opioid receptor systems for the treatment of drug addiction.

Authors:  T S Shippenberg; A LeFevour; V I Chefer
Journal:  CNS Neurol Disord Drug Targets       Date:  2008-11       Impact factor: 4.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.